These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12211149)

  • 21. Dopamine agonists.
    Factor SA
    Med Clin North Am; 1999 Mar; 83(2):415-43, vi-vii. PubMed ID: 10093586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis.
    Baker WL; Silver D; White CM; Kluger J; Aberle J; Patel AA; Coleman CI
    Parkinsonism Relat Disord; 2009 May; 15(4):287-94. PubMed ID: 18774743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical studies with ropinirole in Parkinson's disease and RLS.
    Jost WH; Angersbach D; Rascol O
    J Neurol; 2006 Aug; 253 Suppl 4():IV16-21. PubMed ID: 16944351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pergolide monotherapy for Parkinson's disease.
    van der Worp B
    J Neurol; 1999 Oct; 246(10):983-4. PubMed ID: 10610397
    [No Abstract]   [Full Text] [Related]  

  • 25. Pramipexole for Parkinson's disease.
    Ting RM; Force RW
    J Fam Pract; 1998 Jan; 46(1):19-20. PubMed ID: 9451363
    [No Abstract]   [Full Text] [Related]  

  • 26. Ropinirole therapy for Parkinson's disease.
    Pahwa R; Lyons KE; Hauser RA
    Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotigotine: Parkinson's disease: a step backward.
    Prescrire Int; 2008 Apr; 17(94):60. PubMed ID: 18516813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological profiles and clinical effects of ropinirole hydrochloride (ReQuip)].
    Arai H; Minami J
    Nihon Yakurigaku Zasshi; 2007 Oct; 130(4):313-9. PubMed ID: 17938518
    [No Abstract]   [Full Text] [Related]  

  • 30. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 31. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical importance of neuroprotection in Parkinson's disease.
    Riederer P; Gille G; Müller T; Przuntek H; Reichmann H; Riess O; Schwartz A; Schwarz J; Vogt T
    J Neurol; 2002 Oct; 249 Suppl 3():III/53-6. PubMed ID: 12522574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G;
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY; Chung EJ; Park SW; Lee WY
    Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ropinirole in the treatment of Parkinson's disease: an update].
    Vivancos-Matellano F
    Rev Neurol; 2006 May 1-15; 42(9):542-8. PubMed ID: 16676278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine agonists in the treatment of Parkinson's disease.
    Bonuccelli U; Pavese N
    Expert Rev Neurother; 2006 Jan; 6(1):81-9. PubMed ID: 16466315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson's disease.
    Montastruc F; Moulis F; Araujo M; Chebane L; Rascol O; Montastruc JL
    Eur J Clin Pharmacol; 2017 Jan; 73(1):99-103. PubMed ID: 27796464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.
    Thobois S
    Clin Ther; 2006 Jan; 28(1):1-12. PubMed ID: 16490575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine agonists. Their role in the management of Parkinson's disease.
    Rascol O; Ferreira JJ; Thalamas C; Galitsky M; Montastruc JL
    Adv Neurol; 2001; 86():301-9. PubMed ID: 11553990
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of early Parkinson's disease.
    Dickerson LM; Young SE; Simpson WM; Nashelsky J
    Am Fam Physician; 2005 Aug; 72(3):497-500. PubMed ID: 16100865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.